Lenalidomide (CC-5013): An Immunomodulatory Medicinal Product
Health

Lenalidomide (CC-5013): An Immunomodulatory Medicinal Product

Mary kudro
Mary kudro
1 min read

Lenalidomide (previously referred to as CC-5013) is an immunomodulatory medicinal product with potent antineoplastic, anti-angiogenic, and anti-inflammatory properties. The lenalidomide cost is less and can vary. Being an ultimate source of lenalidomide, patients can contact us to buy lenalidomide in approved quantities. For enquiry connect at: [email protected], or dial our TOLL-FREE: 1800-889-1064. Supplied for oral administration, lenalidomide is approved by the EU and FDA to combat multiple myeloma (MM), myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma (MZL) in selected patients. Because of severe teratogenicity, pregnancy should be excluded prior to the start of treatment.

0

Discussion (0 comments)

0 comments

No comments yet. Be the first!